153 related articles for article (PubMed ID: 25810703)
1. Hypodontia phenotype in patients with epithelial ovarian cancer.
Fekonja A; Cretnik A; Zerdoner D; Takac I
Radiol Oncol; 2015 Mar; 49(1):65-70. PubMed ID: 25810703
[TBL] [Abstract][Full Text] [Related]
2. Hypodontia prevalence and pattern in women with epithelial ovarian cancer.
Fekonja A; Čretnik A; Takač I
Angle Orthod; 2014 Sep; 84(5):810-4. PubMed ID: 24689849
[TBL] [Abstract][Full Text] [Related]
3. Hypodontia as a risk marker for epithelial ovarian cancer: a case-controlled study.
Chalothorn LA; Beeman CS; Ebersole JL; Kluemper GT; Hicks EP; Kryscio RJ; DeSimone CP; Modesitt SC
J Am Dent Assoc; 2008 Feb; 139(2):163-9. PubMed ID: 18245684
[TBL] [Abstract][Full Text] [Related]
4. Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer.
Tattersall A; Ryan N; Wiggans AJ; Rogozińska E; Morrison J
Cochrane Database Syst Rev; 2022 Feb; 2(2):CD007929. PubMed ID: 35170751
[TBL] [Abstract][Full Text] [Related]
5. Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer.
Wuntakal R; Seshadri S; Montes A; Lane G
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD011322. PubMed ID: 27356090
[TBL] [Abstract][Full Text] [Related]
6. [Clinical characteristics of borderline ovarian tumors and stage I epithelial ovarian cancer: an analysis of 143 cases].
Zhao Y; Wang Y; Shen Dh; Song Rn; Xu Q; Li Y; Cui H; Tang J; Wei Lh
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Feb; 43(1):123-8. PubMed ID: 21321635
[TBL] [Abstract][Full Text] [Related]
7. Circulating ciRS-7 as a potential non-invasive biomarker for epithelial ovarian cancer: An investigative study.
Beilerli A; Begliarzade S; Sufianov A; Ilyasova T; Liang Y; Beylerli O
Noncoding RNA Res; 2022 Sep; 7(3):197-204. PubMed ID: 35991513
[TBL] [Abstract][Full Text] [Related]
8. [The relationship of preoperativelymphocyte-monocyte ratio and the clinicopathological characteristics and prognosis of patients with epithelial ovarian cancer].
Yang HM; Lou G
Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):676-680. PubMed ID: 28926896
[No Abstract] [Full Text] [Related]
9. High grade, advanced, serous ovarian cancer with low serum CA125 levels.
Asali A; Haj-Yehia N; Zehavi T; Perry T; Beiner M; Fishman A; Kadan Y
J Obstet Gynaecol; 2021 Oct; 41(7):1107-1111. PubMed ID: 33427544
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of inflammatory markers for distinguishing malignant and benign ovarian masses.
Eo WK; Kim KH; Park EJ; Kim HY; Kim HB; Koh SB; Namkung J
J Cancer; 2018; 9(7):1165-1172. PubMed ID: 29675097
[No Abstract] [Full Text] [Related]
11. Early-Stage epithelial ovarian cancer: Predictors of survival.
Upadhyay A; Garg V; Mathur S; Singh Malik P; Bhatla N; Kumar S; Khurana S; Kumar L
Gynecol Oncol Rep; 2022 Dec; 44():101083. PubMed ID: 36277028
[TBL] [Abstract][Full Text] [Related]
12. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421
[TBL] [Abstract][Full Text] [Related]
13. Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer.
Lawal AO; Musekiwa A; Grobler L
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD009620. PubMed ID: 23740789
[TBL] [Abstract][Full Text] [Related]
14. Case-control study of metabolic syndrome and ovarian cancer in Chinese population.
Chen Y; Zhang L; Liu W; Wang K
Nutr Metab (Lond); 2017; 14():21. PubMed ID: 28261315
[TBL] [Abstract][Full Text] [Related]
15. Correlation between plasma PSGL-1 and FIGO stage, tumor metastasis, and survival in epithelial ovarian cancer.
Li W; Fang C; Gao Y; Gao Y; Yan F; Chen B; Xu M
Biotechnol Appl Biochem; 2024 Mar; ():. PubMed ID: 38494670
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis.
Suri A; Perumal V; Ammalli P; Suryan V; Bansal SK
Sci Rep; 2021 Aug; 11(1):17308. PubMed ID: 34453074
[TBL] [Abstract][Full Text] [Related]
17. Relationship between PIWIL1 gene polymorphisms and epithelial ovarian cancer susceptibility among southern Chinese woman: a three-center case-control study.
Liu S; Yan Y; Cui Z; Feng H; Zhong F; Liu Z; Li Y; Ou X; Li W
BMC Cancer; 2023 Nov; 23(1):1149. PubMed ID: 38012622
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of tranexamic acid in reducing blood loss during cytoreductive surgery for advanced ovarian cancer.
Kietpeerakool C; Supoken A; Laopaiboon M; Lumbiganon P
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011732. PubMed ID: 26801659
[TBL] [Abstract][Full Text] [Related]
19. Role of protein tyrosine phosphatase receptor type M in epithelial ovarian cancer progression.
Li X; Ding W; Rao Y; Qu P
J Ovarian Res; 2023 Jul; 16(1):131. PubMed ID: 37403117
[TBL] [Abstract][Full Text] [Related]
20. Fertility-sparing surgery and survival among reproductive-age women with epithelial ovarian cancer in 2 cancer registries.
Crafton SM; Cohn DE; Llamocca EN; Louden E; Rhoades J; Felix AS
Cancer; 2020 Mar; 126(6):1217-1224. PubMed ID: 31774553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
